Table 3.
Protocol for Assessment of Hydroxychloroquine (Plaquenil®) Toxicity.
Date of examination: | ________________________________________________ | |
Date of initiation of therapy: | ________________________________________________ | |
Total cumulative dose: | ________________________________________________ | |
Diagnosis: | ________________________________________________ | |
________________________________________________ | ||
________________________________________________ | ||
Investigations: | Right eye | Left eye |
1. Visual acuity (corrected) | _____________ | ____________ |
2. Funduscopy | _____________ | ____________ |
3. Visual fields 10-2 (Fovea, OU) | _____________ | ____________ |
4. Multifocal electroretinogram (ERG) | _____________ | ____________ |
5. OCT (Macula) | _____________ | ____________ |
6. Fundus photograph | _____________ | ____________ |
7. Fundus autofluorescence | _____________ | ____________ |
Risk factors: | ||
1. Duration > 5 years | Yes _________ | No _________ |
2. Daily dose >6.5 mg/kg/day of ideal weight | Yes _________ | No _________ |
3. Renal or Hepatic disease | Yes _________ | No _________ |
4. Age >60 years | Yes _________ | No _________ |
5. Pre-existing macular disease | Yes _________ | No _________ |